All Stories

  1. 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr David S Goldstein

  2. Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr David S Goldstein

  3. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders

    Article • Pharmacology & Therapeutics, December 2014, Elsevier

    Dr David S Goldstein

  4. Dysautonomia in Parkinson Disease

    Article • March 2014, Wiley

    Dr David S Goldstein

  5. Theme E Neurology

    Article • January 2014, Elsevier

    Dr David S Goldstein

  6. Cardiac Sympathetic Denervation

    Article • January 2014, Elsevier

    Dr David S Goldstein

  7. Theme C Metabolism

    Article • January 2014, Elsevier

    Dr David S Goldstein

  8. Theme J Catecholamine Interactions with Other Transmitters

    Article • January 2014, Elsevier

    Dr David S Goldstein

  9. Theme D Catecholamine Receptors and Catecholaminergic Signaling

    Article • January 2014, Elsevier

    Dr David S Goldstein

  10. Theme A Catecholamine Biosynthesis and Storage

    Article • January 2014, Elsevier

    Dr David S Goldstein

  11. Theme B Catecholamine Release and Re-uptake

    Article • January 2014, Elsevier

    Dr David S Goldstein

  12. Theme I Catecholamines in Integrative Function

    Article • January 2014, Elsevier

    Dr David S Goldstein

  13. Theme H Catecholamines in the Periphery

    Article • January 2014, Elsevier

    Dr David S Goldstein

  14. Theme F Psychiatry and Psychology

    Article • January 2014, Elsevier

    Dr David S Goldstein

  15. Theme G Drug Abuse and Addiction

    Article • January 2014, Elsevier

    Dr David S Goldstein

  16. Willie Sutton’s Getaway Car and the Pathogenesis of Parkinson Disease

    Article • January 2014, Elsevier

    Dr David S Goldstein

  17. Concepts of Scientific Integrative Medicine Applied to the Physiology and Pathophysiology of Catecholamine Systems

    Article • October 2013, Wiley

    Dr David S Goldstein

  18. Sympathetic neuroimaging

    Article • January 2013, Elsevier

    Dr David S Goldstein

  19. Autonomic dysfunction in Parkinson disease

    Article • January 2013, Elsevier

    Dr David S Goldstein

  20. Differential responses of components of the autonomic nervous system

    Article • January 2013, Elsevier

    Dr David S Goldstein

  21. Cardiovascular Autonomic Dysfunction in Parkinson’s Disease

    Article • October 2012, Springer Science + Business Media

    Dr David S Goldstein

  22. Vesicular uptake blockade generates the toxic dopamine metabolite 3,4‐dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease

    Article • Journal of Neurochemistry, October 2012, Wiley

    Dr David S Goldstein

  23. Temporary elimination of orthostatic hypotension by norepinephrine infusion

    Article • Clinical Autonomic Research, September 2012, Springer Science + Business Media

    Dr David S Goldstein

  24. Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis

    Article • Neurobiology of Disease, June 2012, Elsevier

    Dr David S Goldstein

  25. Stress, Allostatic Load, Catecholamines, and Other Neurotransmitters in Neurodegenerative Diseases

    Article • Cellular and Molecular Neurobiology, February 2012, Springer Science + Business Media

    Dr David S Goldstein

  26. Clinical Sympathetic Imaging

    Article • January 2012, Elsevier

    Dr David S Goldstein

  27. Noradrenergic Neurotransmission

    Article • January 2012, Elsevier

    Dr David S Goldstein

  28. Autonomic dysfunction in PD: A window to early detection?

    Article • Journal of the Neurological Sciences, November 2011, Elsevier

    Dr David S Goldstein

  29. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease

    Article • Journal of the Neurological Sciences, November 2011, Elsevier

    Dr David S Goldstein

  30. Biomarkers, Mechanisms, and Treatment of Autonomic Failure in Parkinson Disease and Related Disorders

    Article • Autonomic Neuroscience, September 2011, Elsevier

    Dr David S Goldstein

  31. Patients as a Scientific Resource: Comments on Receiving the Ahrens Award

    Article • Clinical and Translational Science, August 2011, Wiley

    Dr David S Goldstein

  32. Effects of Carbidopa and Entacapone on the Metabolic Fate of the Norepinephrine Prodrug L-DOPS

    Article • The Journal of Clinical Pharmacology, January 2011, Wiley

    Dr David S Goldstein

  33. Neurocardiology: Therapeutic Implications for Cardiovascular Disease

    Article • Cardiovascular Therapeutics, November 2010, Wiley

    Dr David S Goldstein

  34. Adrenal Responses to Stress

    Article • Cellular and Molecular Neurobiology, November 2010, Springer Science + Business Media

    Dr David S Goldstein

  35. Cardiac Sympathetic Neuroimaging in Dementia with Lewy Bodies

    Article • Journal of Neuroimaging, October 2010, Wiley

    Dr David S Goldstein

  36. Adrenaline and Noradrenaline

    Article • September 2010, Wiley

    Dr David S Goldstein

  37. Catecholamines 101

    Article • Clinical Autonomic Research, July 2010, Springer Science + Business Media

    Dr David S Goldstein

  38. Cardiac ectopy in chronic autonomic failure

    Article • Clinical Autonomic Research, December 2009, Springer Science + Business Media

    Dr David S Goldstein

  39. Cardiac sympathetic neuroimaging: summary of the First International Symposium

    Article • Clinical Autonomic Research, March 2009, Springer Science + Business Media

    Dr David S Goldstein

  40. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations

    Article • Autonomic Neuroscience, March 2009, Elsevier

    Dr David S Goldstein

  41. Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension

    Article • Parkinsonism & Related Disorders, February 2009, Elsevier

    Dr David S Goldstein

  42. Computer Models of Stress, Allostasis, and Acute and Chronic Diseases

    Article • Annals of the New York Academy of Sciences, December 2008, Wiley

    Dr David S Goldstein

  43. CLINICAL EVALUATION OF THE AUTONOMIC NERVOUS SYSTEM

    Article • CONTINUUM Lifelong Learning in Neurology, December 2007, Wolters Kluwer Health

    Dr David S Goldstein

  44. AUTONOMIC FAILURE IN NEURODEGENERATIVE DISORDERS

    Article • CONTINUUM Lifelong Learning in Neurology, December 2007, Wolters Kluwer Health

    Dr David S Goldstein

  45. Adrenaline and Noradrenaline

    Article • August 2007, Wiley

    Dr David S Goldstein

  46. Cardiac Sympathetic Neuroimaging

    Article • July 2007, Taylor & Francis

    Dr David S Goldstein

  47. Evolution of concepts of stress

    Article • Stress, January 2007, Taylor & Francis

    Dr David S Goldstein

  48. Autonomic dysfunction in Parkinson's disease

    Article • January 2007, Elsevier

    Dr David S Goldstein

  49. Prevalence of anti-locus coeruleus immunoreactivity in CSF of patients with autonomic failure

    Article • Clinical Autonomic Research, September 2006, Springer Science + Business Media

    Dr David S Goldstein

  50. L‐Dihydroxyphenylserine (L‐DOPS): A Norepinephrine Prodrug

    Article • Cardiovascular Drug Reviews, September 2006, Wiley

    Dr David S Goldstein

  51. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope

    Article • Clinical Science, September 2006, Portland Press Ltd.

    Dr David S Goldstein

  52. Orthostatic hypotension as an early finding in Parkinson’s disease

    Article • Clinical Autonomic Research, February 2006, Springer Science + Business Media

    Dr David S Goldstein

  53. Complex Regional Pain Syndromes

    Article • January 2006, Elsevier

    Dr David S Goldstein

  54. Faculty Opinions recommendation of Profound cardiac sympathetic denervation occurs in Parkinson disease.

    Article • April 2005, F1000Research

    Dr David S Goldstein

  55. Functional Neuroimaging of Sympathetic Innervation of the Heart

    Article • Annals of the New York Academy of Sciences, June 2004, Wiley

    Dr David S Goldstein

  56. Noradrenergic Neurotransmission

    Article • January 2004, Elsevier

    Dr David S Goldstein

  57. Spinal cord stimulation for chronic reflex sympathetic dystrophy

    Article • Annals of Neurology, December 2003, Wiley

    Dr David S Goldstein

  58. Dysautonomia in Parkinson's disease: neurocardiological abnormalities

    Article • The Lancet Neurology, November 2003, Elsevier

    Dr David S Goldstein

  59. Pheochromocytoma: Rediscovery as a catecholamine-metabolizing tumor

    Article • Endocrine Pathology, September 2003, Springer Science + Business Media

    Dr David S Goldstein

  60. Dysautonomias: Clinical Disorders of the Autonomic Nervous System

    Article • Annals of Internal Medicine, November 2002, American College of Physicians

    Dr David S Goldstein

  61. Progressive loss of cardiac sympathetic innervation in Parkinson's disease

    Article • Annals of Neurology, July 2002, Wiley

    Dr David S Goldstein

  62. Catecholamine Research

    Article • January 2002

    Dr David S Goldstein

  63. Cardiac Sympathetic Denervation in Parkinson’s Disease

    Article • January 2002, Springer Science + Business Media

    Dr David S Goldstein

  64. Sympathetic Neurocirculatory Failure in Parkinson Disease: Evidence for an Etiologic Role of α-Synuclein

    Article • Annals of Internal Medicine, December 2001, American College of Physicians

    Dr David S Goldstein

  65. Sympathetic Nervous System Physiology and Pathophysiology in Coping with the Environment

    Article • December 2001, Wiley

    Dr David S Goldstein

  66. Catecholamines in the Brain and Responses to Environmental Challenges

    Article • December 2001, Wiley

    Dr David S Goldstein

  67. Cardiac sympathetic neuroimaging to distinguish multiple system atrophy from Parkinson disease

    Article • Clinical Autonomic Research, December 2001, Springer Science + Business Media

    Dr David S Goldstein

  68. Adrenaline and Noradrenaline

    Article • April 2001, Wiley

    Dr David S Goldstein

  69. Noninvasive detection of sympathetic neurocirculatory failure

    Article • Clinical Autonomic Research, October 2000, Springer Science + Business Media

    Dr David S Goldstein

  70. Estimation of striatal dopamine spillover and metabolism in vivo

    Article • Neuroreport, October 2000, Wolters Kluwer Health

    Dr David S Goldstein

  71. Cardiac Sympathetic Denervation in Parkinson Disease

    Article • Annals of Internal Medicine, September 2000, American College of Physicians

    Dr David S Goldstein

  72. Sympathetic innervation and function in reflex sympathetic dystrophy

    Article • Annals of Neurology, July 2000, Wiley

    Dr David S Goldstein

  73. Sympathetic innervation and function in reflex sympathetic dystrophy

    Article • Annals of Neurology, July 2000, Wiley

    Dr David S Goldstein

  74. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer’s disease

    Article • Biological Psychiatry, September 1999, Elsevier

    Dr David S Goldstein

  75. α2-Adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats

    Article • Brain Research, May 1999, Elsevier

    Dr David S Goldstein

  76. Monoaminergic effects of high‐dose corticotropin in corticotropin‐responsive pediatric opsoclonus‐myoclonus

    Article • Movement Disorders, May 1998, Wiley

    Dr David S Goldstein

  77. The Eighth International Catecholamine Symposium

    Article • Experimental Neurology, June 1997, Elsevier

    Dr David S Goldstein

  78. Preface

    Article • January 1997, Elsevier

    Dr David S Goldstein

  79. Catecholamine Receptors and Signal Transduction

    Article • January 1997, Elsevier

    Dr David S Goldstein

  80. Novel Catecholaminergic Systems

    Article • January 1997, Elsevier

    Dr David S Goldstein

  81. Catecholamines in the Periphery

    Article • January 1997, Elsevier

    Dr David S Goldstein

  82. Sympathetic Carondioneuropathy in Dysautonomias

    Article • January 1997, Elsevier

    Dr David S Goldstein

  83. Dopamine β-Hydroxylase Deficiency Associated with Mutations in a Copper Transporter Gene

    Article • January 1997, Elsevier

    Dr David S Goldstein

  84. Norepinephrine and Schizophrenia: A New Hypothesis for Antipsychotic Drug Action

    Article • January 1997, Elsevier

    Dr David S Goldstein

  85. The Effects of clozapine on plasma norepinephrine kinetics in schizophrenic patients

    Article • Schizophrenia Research, January 1997, Elsevier

    Dr David S Goldstein

  86. Glucocorticoid-induced sympathoinhibition in humans

    Article • Clinical Pharmacology & Therapeutics, July 1995, Wiley

    Dr David S Goldstein

  87. Prothrombotic Effects of Environmental Stress

    Article • Psychosomatic Medicine, January 1995, Wolters Kluwer Health

    Dr David S Goldstein, David S. Krantz

  88. Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans

    Article • Biological Psychiatry, November 1992, Elsevier

    Dr David S Goldstein

  89. Central Catecholamines and the Control of Sympathetic Tone

    Article • January 1992, Springer Science + Business Media

    Dr David S Goldstein

  90. Stress and sodium hypertension in baboons

    Article • Journal of Hypertension, October 1991, Wolters Kluwer Health

    Dr David S Goldstein

  91. Chronic effects of high salt intake and conflict stress on blood pressure in primates

    Article • Integrative Psychological and Behavioral Science, October 1991, Springer Science + Business Media

    Dr David S Goldstein

  92. Neurotransmitters and stress

    Article • September 1990

    Dr David S Goldstein

  93. Altered norepinephrine regulation in bulimia: Effects of pharmacological challenge with isoproterenol

    Article • Psychiatry Research, July 1990, Elsevier

    Dr David S Goldstein

  94. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension

    Article • Annals of Neurology, October 1989, Wiley

    Dr David S Goldstein

  95. State-related changes in norepinephrine regulation in anorexia nervosa

    Article • Biological Psychiatry, February 1989, Elsevier

    Dr David S Goldstein

  96. Stress-induced activation of the sympathetic nervous system

    Article • Baillière s Clinical Endocrinology and Metabolism, May 1987, Elsevier

    Dr David S Goldstein

  97. Plasma 3, 4-Dihydroxyphenylalanine (Dopa) and Catecholamines in Neuroblastoma or Pheochromocytoma

    Article • Annals of Internal Medicine, December 1986, American College of Physicians

    Dr David S Goldstein

  98. Autonomic Failure: A Textbook of Clinical Disorders of the Autonomic Nervous System

    Article • Archives of Internal Medicine, March 1985, American Medical Association (AMA)

    Dr David S Goldstein

  99. Neural circulatory control in the hyperdynamic circulatory state syndrome

    Article • American Heart Journal, February 1985, Elsevier

    Dr David S Goldstein

  100. Clonidine Suppression Testing in Essential Hypertension

    Article • Annals of Internal Medicine, January 1985, American College of Physicians

    Dr David S Goldstein

  101. Pressor and depressor responses after cholinergic blockade in humans

    Article • American Heart Journal, May 1984, Elsevier

    Dr David S Goldstein

  102. Position Paper: The Sympathetic Nervous System and Hypertension

    Article • January 1981, Springer Science + Business Media

    Dr David S Goldstein

  103. Visceral Learning: Cardiovascular Conditioning in Primates

    Article • January 1977, Springer Science + Business Media

    Dr David S Goldstein

  104. Cognition of arousal and actual arousal as determinants of emotion.

    Article • Journal of Personality and Social Psychology, January 1972, American Psychological Association (APA)

    Dr David S Goldstein

  105. Cardiovascular Autonomic Dysfunction

    Article • Springer Science + Business Media

    Dr David S Goldstein